medigraphic.com

2019, Number 4

<< Back Next >>

Rev Mex Anest 2019; 42 (4)

Locally applied sevoflurane: an analgesic and therapeutic alternative in difficulty chronic skin ulcers

López‑Riascos SD, Rivas‑Ramírez C, Carrillo‑Torres O

Language: Spanish
References: 27
Page: 268-274
PDF size: 368.05 Kb.


ABSTRACT

Chronic ulcers in the lower limbs are frequent, mainly in pathologies of vascular origin and cause a decrease in the patients’ quality of life, due to the time and cost of the treatment, especially when they are refractory to conventional therapeutic and analgesic measures. Those who present these lesions usually suffer from comorbidities that require multiple drugs for their control, so it is necessary to use alternatives, which reduce the risk of drug interactions and adverse effects. One of them is considered the local application of sevoflurane, as an anesthetic technique in the surgical lavage and/or debridement of ulcers, due to the rapid, intense and long-lasting analgesia it produces.


REFERENCES

  1. Tatsioni A, Balk E, O’Donnell T, et al. Usual care in the management of chronic wounds: a review of the recent literature. J Am Coll Surg. 2007;205:617-624.

  2. Graham IA, Harrison MB, Nelson EA, et al. Prevalence of lower-limb ulceration: a systematic review of prevalence studies. Adv Skin Wound Care. 2003;6:305-316.

  3. Pitsch F. Vein consult program: interim results from the first 70,000 screened patients in 13 countries. Phlebolymphology. 2012;19:132-137.

  4. O’Donnell TF, Passman MA, Marston WA, et al. Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2014;60:3S-59S.

  5. Franks PJ, Barker J, Collier M, et al. Management of patients with venous leg ulcers, challenges and current best practice. J Wound Care. 2016;25:s1-s67.

  6. Raffetto JD. Which dressings reduce inflammation and improve venous leg ulcer healing. Phlebology. 2014;29:157-164.

  7. Briggs M, Nelson AE, Martyn-St James M. Topical agents or dressings for pain in venous leg ulcers. Cochrane Database of Systematic Reviews 2012; 11. Art. No.: CD001177. doi: 10.1002/14651858.CD001177.pub3.

  8. Fassoulaki A, Sarantopoulus C, Karabinis G, et al. Skin application of isoflurane attenuates the responses to a mechanical and an electrical stimulation. Can J Anaesth. 1998;45:1151-1155.

  9. Petersen-Felix S, Arendt-Nielsen L, Bak P, et al. The effects of isoflurane on repeated nociceptive stimuli (central temporal summation). Pain. 1995;64:277-2781.

  10. Petersen-Felix S, Arendt-Nielsen L, Bak P, et al. Analgesic effect in humans of subanaesthetic isoflurane concentrations evaluated by experimentally induced pain. Br J Anaesth. 1995;75:55-60.

  11. Fassoulaki A, Lockhart SH, Freire BA, et al. Percutaneous loss of desflurane, isoflurane, and halothane in humans. Anesthesiology. 1991;74:479-483.

  12. Chu CC, Wu SZ, Su WL, et al. Subcutaneous injection of inhaled anesthetics produces cutaneous analgesia. Can J Anaesth. 2008;55:290-294.

  13. Rehberg B, Xiao Y-H, Duch DS. Central nervous system sodium channels are significantly suppressed at clinical concentrations of volatile anesthetics. Anesthesiology. 1996;84:1223-1233.

  14. Ouyang W, Hemmings HC Jr. Depression by isoflurane of the action potential and underlying voltage-gated ion currents in isolated rat neurohypophysial nerve terminals. J Pharmacol Exp Ther. 2005;312:801-808.

  15. Ouyang W, Wang G, Hemmings HC Jr. Isoflurane and propofol inhibit voltage-gated sodium channels in isolated rat neurohypophysial nerve terminals. Mol Pharmacol. 2003;64:373-381.

  16. Matute E, Rivera-Arconada I, López-García JA. Effects of propofol and sevoflurane on the excitability of rat spinal motoneurones and nociceptive reflexes in vitro. Br J Anaesth. 2004;93:422-427.

  17. Lafuente RF, Gilaberte Y. Sevoflurano, ¿una alternativa en el tratamiento de las úlceras vasculares? Actas Dermo Sifiliográficas. 2014;105:202-203.

  18. Gerónimo-Pardo M, Martínez A, Martínez M. Analgesic effect of topical sevoflurane on venous leg ulcer with intractable pain. Phlebologie. 2011;40:95-97.

  19. Martínez A, Gerónimo-Pardo M. Sevoflurano como anestésico local en herida isquémica de paciente cardiópata con insuficiencia respiratoria secundaria a morfina. Heridas y Cicatrización. 2011;6:46-49.

  20. Gerónimo-Pardo M, Martínez M, Martínez A, Rueda JL. Usos alternativos del sevoflurano. Efecto analgésico tópico. Rev Electron Anestesia R. 2012;4:181.

  21. Martínez M, Gerónimo-Pardo M, Crespo MD. Actividad bactericida del sevoflurano frente a Stafilococcus aureus, Pseudomonas aeruginosa y Escherichia coli. Enferm Infecc Microbiol Clin. 2009;27:120-121.

  22. De Leon-Casasola OA. Multimodal approaches to the management of neuropathic pain: the role of topical analgesia. J Pain Symptom Manage. 2007;33:356-364.

  23. Pardo MG, Martínez A. Efecto analgésico local de sevoflurano irrigado tópicamente sobre úlceras venosas dolorosas. 17ª Reunión Anual ESRA España. Barcelona, 5-7 de octubre de 2011.

  24. Fernández FD, Cortiñas M, Fernández C, et al. Sevoflurano tópico: una nueva opción terapéutica paliativa en las úlceras cutáneas. Med Paliat. 2015.

  25. AbbVie, FT-61451.2007. Ficha técnica del producto (Sevorane®). [Consultado 20 Ene 2015]: Disponible en: http://www.aemps.gob.es/cima/pdfs/es/ft/61451/61451 ft. pdf.

  26. Saus C, Herreros ML, Sánchez-Bermejo MA et al. Empleo de sevoflurano de forma tópica como analgésico en curas de heridas crónicas de origen vascular. Resultados preliminares. XXVII Congreso Nacional de Enfermería vascular y heridas. España. Castellón, 4-5 de Junio de 2015.

  27. Behne M, Hans-Joachim W, Harder S. Clinical pharmacokinetics of sevoflurane. Clin Pharmacokinet. 1999;36:13-26.




2020     |     www.medigraphic.com